REFERENCES
- Brown TD, Gastrointestinal Cancer. In Weiss GR, Clinical Oncology, Lange Medical Book, Connecticut, USA, 1993.
- Ahlgren JD. Chemotherapy for pancreatic carcinoma. Cancer 1996; 78: 654–663.
- Bolli E, Saccomano S, Mondini G, et al. 5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. Cancer Chemother Pharmacol 1995; 35: 339–342.
- MacDonald JS, Schein PS, Wooley PV. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 1980; 93: 533–536.
- Formasiero A, Cartel G, Daniele 0, et al. FAM2 regimen in disseminated gastric cancer. Tumori 1984; 70: 77–80.
- Takada T, Kato H, Matsushiro T, et al. Prospective ran-domized trial comparing 1/2 FAM (5-fluorouracil + Adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcino-mas. Can To Kagaku Ryoho 1996; 23: 707–714.
- Karlin DA, Stroehlein JR, Bennetts RW, et al. Phase I-II study of the combination of 5-FU, doxorubicin, mitomycin, and semustin (FAMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Cancer Treat Rep 1982; 66: 1613-1617.
- Preusser P, Wilke H, Achterrath W, et al. Phase I-II study with EAP (etoposide, Adriamycin, cisplatin) in advanced gastric cancer, abstract. Proc EORTC Symposium on Gastrointestinal Tract Cancer, Update on Combined Modality Treatment. Heidelberg, 1986.
- Klein HO, Dias Wickramanayake P, Farrokh GH. 5-Fluorouracil, Adriamycin, and methotrexate—a combined pro-tocol (FAMTX) for the treatment of metastasized stomach can-cer. Proc ASCO 1986; 5: 84.
- Moertel CG, Rubin J, O'Connel MJ, Schutt AJ, Wieand HS. A phase II study of combined 5-fluorouracil,dox-orubicin,and cisplatin in the treatment of advanced upper gas-trointestinal adenocarcinomas. J Clin Oncol 1986; 4: 1053-1057.
- Machover D, Goldschmidt E, Chollet P, Metzger G, et al. Treatment of advanced colorectal and gastric adenocarcino-mas with 5-fluorouracil and high dose folinic acid. NCI Monogr 1987; (5): 193-198.
- Cunningham D, Gilchrist NL, Forrest GJ, et al. Chemotherapy in advanced gastric cancer. Cancer Treat Rep 1985; 69: 927–928.
- Tsavaris N, Mylonakis N, Bacoyiannis Ch, et al. Combined epirubicin, 5-fluorouracil, leucovorin, with allopuri-nol protection in the treatment of advanced gastric cancer. A pilot study. Onkologie 1995; 18: 346–350.
- Miller A, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–217.
- Kaplan EL, Meier P. Non parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
- Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170.
- Schnall SF, MacDonald JS. Chemotherapy of adenocar-cinoma of the pancreas. Semin Oncol 1996; 23: 220–228.
- Glimelius B, Hoffman K, Sjoden PO, et al. Chemotherapy improves survival in advanced pancreatic and biliary cancer. Ann Oncol 1996; 7: 593–600.